Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Dignify Therapeutics has raised $1.2M in total funding. The most recent round was Grant. The last funding was announced in September 2024.
Dignify Therapeutics's investors include RA Capital Management, National Institutes of Health, National Institute on Aging, North Carolina Biotechnology Center, Eshelman Ventures.
Dignify Therapeutics is headquartered in Raleigh, United States.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Dignify Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dignify Therapeutics — Funding & Investors." VCBacked, September 19, 2024, https://www.vcbacked.co/company/dignify-therapeutics. Accessed August 13, 2026.
VCBacked. (2024). Dignify Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/dignify-therapeutics
{{cite web |title=Dignify Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dignify-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated